https://scholars.lib.ntu.edu.tw/handle/123456789/146103
標題: | Schedule-Dependence of C-Cam1 Adenovirus Gene Therapy in a Prostate Cancer Model | 作者: | LIN, SHU-WHA PU, YEONG-SHIAU LUO, WEI- PING WANG, YAN |
關鍵字: | cell adhesion molecule;tumor suppressor;gene therapy;adenovirus;prostatic neoplasms | 公開日期: | 1999 | 卷: | v.19 | 期: | n.1A | 起(迄)頁: | 337-340 | 來源出版物: | ANTICANCER RESEARCH | 摘要: | BACKGROUND: C-CAM1 functions as a tumor suppressor in prostate cancer. Thus C-CAM1 recombinant adenovirus therapy may be a promising treatment for prostate cancer. Understanding the time course of C-CAM1's antitumor activity is essential for designing an optimal schedule for C-CAM1 gene therapy. MATERIALS AND METHODS: PC3 cells were exposed to Ad-C-CAM1 and the time course of C-CAM1 expression was monitored by flow cytometry. Tumors generated in nude mice by subcutaneous injection of PC-3 cells were used for in vivo testing of C-CAM1's antitumor activity. Intratumoral injections of viruses (either Ad-C-CAM1 or Ad-beta-gal) or buffer only ( control) were performed according to two different schedules. Mice in Schedule A received a single injection, while mice in Schedule B received the same total amount of viruses in 3 equal doses at 2-week intervals. RESULTS: After single exposure to Ad-C-CAM1, PC-3 cells expressed abundant C-CAM1 protein which reached the highest level on day 3 and persisted for up to 5 days. PC-3 tumors in nude mice exhibited 2 to 3-week lag in tumor growth curves after a single Ad-C-CAM1 injection. In contrast, 14 of the 18 tumors receiving 3 fractionated Ad-C-CAM1 injections regressed completely, while the other 4 tumors shrank to significantly smaller sizes . CONCLUSIONS: Sustained expression of C-CAM1 is required for optimal tumor suppression. The schedule-dependence of C-CAM1's antitumor activity should be taken into account in optimizing gene therapy in clinical settings. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/105258 |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。